Tesofensine boosts serotonin, noradrenaline, and dopamine availability in the brain, leading to noteworthy improvements in obesity-related endocrine factors like body weight and fat, and waist circumference. It offers double the weight loss compared to approved anti-obesity drugs. Originally intended for Alzheimer’s and Parkinson’s, Tesofensine consistently reduced weight in test subjects, prompting researchers to explore its use as an anti-obesity medication. It’s presently in phase 3 clinical trials for obesity.